Seelos Therapeutics Announces Additional Interim Data from Phase I Studies of Intranasal Racemic Ketamine (SLS-002)
February 26, 2020 08:01 ET
|
Seelos Therapeutics, Inc.
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Operation Lifesaver introduces resource for news media reporting on suicide-related rail incidents
January 14, 2020 10:00 ET
|
Operation Lifesaver
Washington, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Operation Lifesaver, Inc., (OLI) the national, nonprofit rail safety education organization, is providing a new resource that offers effective messaging...
Seelos Therapeutics Announces Interim Data from Phase I Study of Intranasal Racemic Ketamine (SLS-002)
January 10, 2020 07:31 ET
|
Seelos Therapeutics, Inc.
NEW YORK, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Seelos Therapeutics Schedules Type C Meeting with FDA to Discuss Intranasal Racemic Ketamine Program (SLS-002)
January 06, 2020 08:02 ET
|
Seelos Therapeutics, Inc.
NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Highmark Interactive to Launch Therapeutic Trials Using Software to Treat Concussion, Mental Health and More
December 05, 2019 09:10 ET
|
Highmark Interactive
TORONTO, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Highmark Interactive, an award-winning digital health company, is announcing their intention to begin therapeutic trials utilizing their FDA-cleared ‘EQ...
Seelos Therapeutics Announces Dosing of Phase I PK/PD Study of Intranasal Racemic Ketamine (SLS-002)
November 27, 2019 11:00 ET
|
Seelos Therapeutics, Inc.
NEW YORK, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
New Report Reveals Worsening Disparities in Access to Behavioral Healthcare for Employer-Sponsored Health Plans
November 20, 2019 10:16 ET
|
The Bowman Family Foundation
-Addiction Treatment Disparities for Inpatient, Outpatient Facility, and Office Visits are Stark Despite the National Opioid Crisis -Children’s Use of Out-of-Network Mental Health Office Visits is...
Trupanion Supports Australia’s Veterinary Professionals in their Mental Wellbeing through MightyVet
October 15, 2019 15:37 ET
|
Trupanion
MightyVet connects industry professionals in Australia and beyond with valuable resources Focuses on burnout, compassion fatigue, ethics exhaustion, resiliency, and suicide prevention SEATTLE, Oct. ...
American Addiction Centers Partners With Former BMX Elite Pro Tony Hoffman in New Documentary on the Power of Redemption and Recovery
October 10, 2019 15:08 ET
|
American Addiction Centers, Inc.
BRENTWOOD, Tenn., Oct. 10, 2019 (GLOBE NEWSWIRE) -- American Addiction Centers (AAC), a leading provider of substance use treatment services, released the latest installment of its new docuseries,...
Children's Hospital Launches Bold Initiative to Address Mental Health Crisis
September 17, 2019 17:28 ET
|
Children's Hospital of The King's Daughters
Norfolk, Va, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Eric and Michelle Peterson live every day with the fact that there’s nothing they can do to bring back their daughter, Sarah, who died by suicide five...